Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Fierce Biotech
Roche
antibodies
COVID-19
Flag link:
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Pharmaceutical Business Review
JNJ
vaccines
COVID-19
Europe
blood clots
Flag link:
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Regeneron
antibodies
COVID-19
Flag link:
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
COVID-19
vaccines
CDC
Flag link:
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
NIH
NIH
clinical trials
drug repurposing
COVID-19
Flag link:
The next 2 months in biotech and pharma will be busy. Here's what to watch.
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Biogen
aducanumab
FDA
Vertex Pharmaceuticals
Sarepta Therapeutics
JNJ
AstraZeneca
vaccines
COVID-19
Flag link:
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Forbes
Abbott Labs
COVID-19
earnings
diagnostics
Flag link:
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
Endpoints
Pfizer
Moderna Therapeutics
COVID-19
vaccines
JNJ
AstraZeneca
Flag link:
How Johnson & Johnson Beat Expectations in Q1
How Johnson & Johnson Beat Expectations in Q1
Motley Fool
JNJ
earnings
COVID-19
vaccines
Flag link:
PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward
PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward
Fierce Biotech
Medable
COVID-19
pandemic
funding
decentralized clinical trials
clinical trials
PPD
Flag link:
EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots
EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots
Endpoints
EMA
Europe
JNJ
vaccines
blood clots
COVID-19
Flag link:
Half of US adults have received at least one COVID-19 vaccine dose
Half of US adults have received at least one COVID-19 vaccine dose
Beckers Hospital Review
vaccines
COVID-19
Flag link:
Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount
Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount
Fierce Pharma
Serum Institute
AstraZeneca
COVID-19
vaccines
Flag link:
Fauci Says J&J Vaccine Likely to Resume by Friday
Fauci Says J&J Vaccine Likely to Resume by Friday
BioSpace
JNJ
vaccines
COVID-19
Anthony Fauci
Flag link:
The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
Motley Fool
Moderna Therapeutics
Novavax
Pharma CEOs
vaccines
COVID-19
Stephane Bancel
flu vaccines
Flag link:
Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA
Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA
BioSpace
FDA
COVID-19
Janet Woodcock
Flag link:
FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys
FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys
Fierce Pharma
Emergent BioSolutions
drug manufacturing
vaccines
FDA
COVID-19
Flag link:
Adagio raises a monster $336M round for bespoke COVID-19 drug battle
Adagio raises a monster $336M round for bespoke COVID-19 drug battle
Fierce Biotech
Adagio Therapeutics
COVID-19
Flag link:
South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
Yahoo/Reuters
COVID-19
Pfizer
vaccines
BioNTech
COVID-19 variants
Flag link:
Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles
Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles
Fierce Pharma
Moderna Therapeutics
vaccines
COVID-19
UK
Canada
Europe
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »